JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 12 1951-1958
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoffel, M.
Right arrow Articles by Beckers, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoffel, M.
Right arrow Articles by Beckers, C.

Evaluation of Technetium-99m-L,L-EC in Renal Transplant Recipients: A Comparative Study with Technetium-99m-MAG3 and Iodine-125-OIH

Michel Stoffel, François Jamar, Chris Van Nerom, Alfons Verbruggen, Michel Mourad, Norbert Leners, Jean-Paul Squifflet and Christian Beckers

Center of Nuclear Medicine and Division of Renal Transplantation, University of Louvain Medical School, Brussels
Laboratory of Radiopharmaceutical Chemistry F.F.W., K. U. Leuven, Leuven, Belgium

Correspondence: For correspondence or reprints contact: Dr. M. Stoffel, MD, Center of Nuclear Medicine, University of Louvain Medical School, UCL 5430, Avenue Hippocrate 54, 8-1200 Brussels, Belgium.

ABSTRACT

The clinical usefulness of kit-formulated 99mTc-L,L-EC, a new renal tubular tracer agent based on a diaminodithiol ligand was evaluated in a large population of renal transplant recipients. Methods: Fifty patients with transplants were studied. Five patients with renal insufficiency and five normal volunteers were also included to extend the range of renal function values. The labeling efficiency of 99mTc-L,L-EC in routine conditions, i.e., without HPLC purification, and the safety of the tracer were evaluated. Results: The mean radiochemical purity of 99mTc-L,L-EC determined by thin-layer chromatography was 97.4%. No side effects or significant biochemical changes were observed. The clearance of 99mTc-L,L-EC and 125I-OIH ranged from 10.7 to 417.5 and from 27.6 to 602.7 ml/min/1.73 m2, respectively. The clearance of 99mTc-L,L-EC and 99mTc-MAG3 averaged respectively 71% and 52% of that of 125I-OIH. Conclusion: The labeling procedure of kit-formulated 99mTc-L,L-EC is easy and efficient. This tracer is safe and suitable for both imaging and quantitative measurement of the renal tubular function. Technetium-99m-L,L-EC represents an excellent alternative to 99mTc-MAG3.

Key Words: LLEC • MAG3 • ERPF • tubular tracer • kidney transplant







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.